Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

To further evaluate the safety and efficacy of the Control-IQ closed-loop control (CLC) system in children with type 1 diabetes. After a 16-week randomized clinical trial (RCT) comparing CLC with sensor-augmented pump (SAP) therapy in 101 children 6-13 years old with type 1 diabetes, 22 participants...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2021-02, Vol.44 (2), p.473-478
Hauptverfasser:	Kanapka, Lauren G, Wadwa, R Paul, Breton, Marc D, Ruedy, Katrina J, Ekhlaspour, Laya, Forlenza, Gregory P, Cengiz, Eda, Schoelwer, Melissa J, Jost, Emily, Carria, Lori, Emory, Emma, Hsu, Liana J, Weinzimer, Stuart A, DeBoer, Mark D, Buckingham, Bruce A, Oliveri, Mary, Kollman, Craig, Dokken, Betsy B, Cherñavvsky, Daniel, Beck, Roy W
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Blood Glucose Child Children Control systems Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) Diabetes Mellitus, Type 1 - drug therapy Diabetic ketoacidosis Emerging Technologies: Data Systems and Devices Feedback control Humans Hypoglycemia Hypoglycemic Agents - therapeutic use Insulin - therapeutic use Insulin Infusion Systems Intelligence Ketoacidosis Research design
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!